Nasal delivery devices Market Scope, Analysis, and Trends by 2027
Nasal delivery devices Market Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 58.5 Billion |
| Market Size by 2027 | US$ 95.68 Billion |
| Global CAGR (2019 - 2027) | 6.4% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By Drug Type
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
Nasal Delivery Devices Market – By Drug Type
- Anaesthetics
- Antibiotics
- Pain Relief Drugs
- Calcium Supplements
- Vasoconstrictors
- Antihistamines
- Others
Nasal Delivery Devices Market – By Delivery Technologies
- Spray
- Nebulizers
- Inhalers
- Others
Nasal Delivery Devices Market – By End User
- Home Care Settings
- Hospitals
- Clinics
Nasal Delivery Devices Market – by Geography
- North America
- US
- Canada
- Mexico
- Europe
- France
- Germany
- Italy
- UK
- Spain
- Rest of Europe
- Asia Pacific (APAC)
- China
- India
- South Korea
- Japan
- Australia
- Rest of Asia Pacific
- Middle East & Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
- South and Central America
- Brazil
- Argentina
- Rest of South America
Company Profiles
- GlaxoSmithKline plc.
- AstraZeneca
- Pfizer Inc
- BD
- Sanofi
- Merck & Co., Inc.
- Cadila Pharmaceuticals Ltd.
- Novartis AG
- Dr. Reddy's Laboratories
- Neurelis, Inc
Get Free Sample For